News of Note—Fresenius recalls 163 lots of sodium chloride

Cancer in newspaper clipping
(Pixabay)

> Fresenius Kabi USA is voluntarily recalling 163 lots of Sodium Chloride Injection, because the labels incorrectly state that the stoppers do not contain latex. Release

> Ian Hudson, M.D., chief executive of the Medicines and Healthcare Products Regulatory Agency, has announced he will retire from MHRA in September 2019. Pharmafield article

> CDMO Dalton Pharma Services has a drug development and manufacturing services agreement with stem cell biotech ExCellThera for formulation and fill/finish services at its plant in Toronto, Canada. Release

Sponsored by Lubrizol Life Science

[Webinar] Cannabinoid Formulation - from Farm to Pharma

Wednesday, June 24, 2020 | 12pm ET / 9am PT

A handful of cannabinoid-based pharmaceutical products are on the market today, and an ever-growing number are in the global development pipeline. This webinar will explore key considerations in developing cannabinoid-based pharmaceutical products, including an overview of global pharmaceutical cannabinoid usage today, common challenges formulating with CBD and other cannabinoids, and more.

> Oxford BioMedica will invest £4 million to build digital and robotics capabilities to increase capacity, reduce the cost of manufacturing and reduce waste in its cell manufacturing. Release

Suggested Articles

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.